Results 121 to 130 of about 173,141 (216)

HBV [PDF]

, 2011
openaire   +1 more source

Prevalence and risk factors of hepatitis B infection in rural communities: a cross-sectional analysis. [PDF]

Front Public Health
Asakitogum P, Agana FA, Dede C, Loerzel V, Asakitogum DA.   +4 more
europepmc   +1 more source

The long noncoding RNA MAPKAPK5-AS1 promotes the formation of hepatitis B virus cccDNA by modulating the expression of NABP1. [PDF]

Virulence
Zhang X, Liu T, Jiang Q, Hu Z, Cen S, Zhang Q.   +5 more
europepmc   +1 more source

Donor-recipient Hepatitis B serological patterns and post-transplant HBV events in pediatric living donor liver transplantation: a single-center retrospective cohort with a nested case series. [PDF]

Front Immunol
Le Y, Tang H, Zhang Q, Weng J, Huang L, Dai X, Zhang M.   +6 more
europepmc   +1 more source

Combining antiviral therapy with cancer treatment in HBV-associated HCC: A translational approach. [PDF]

Virus Res
Hashem MA, Kayesh MEH, Kohara M, Tsukiyama-Kohara K.   +3 more
europepmc   +1 more source

Association of Hepatitis B and Hepatitis C Virus Infections With Hepatocellular Carcinoma: A Systematic Review of Virological, Histopathological, and Molecular Evidence. [PDF]

Cureus
Saxena R, Varshney S, Khan MS, Bansal M, Syed R, Sanjaybhai PK, Singh K, Paul R.   +7 more
europepmc   +1 more source

Prevalence of Occult Infection by Hepatitis B Virus in Liver Biopsies in Clinical Practice. [PDF]

Viruses
Horta D, Ramos A, Rifà R, Loras C, Jimenez-Sena M, Raga A, Esteve-Comas M.   +6 more
europepmc   +1 more source

Double-Edged Sword: HBV-Driven Lipid Metabolism Remodeling in Hepatocarcinogenesis Through Ferroptosis Regulation. [PDF]

Viruses
Xia S, Shen X, Chen G, Liu R, Yang X.
europepmc   +1 more source

Ten-Year Outcomes in Liver Transplantation for HBV/HDV Coinfection: A Romanian Single-Center Cohort Study. [PDF]

J Clin Med
Iacob S, Chitul M, Brasoveanu V, Cerban R, Constantinescu I, Dorobantu B, Ester C, Gheorghe C, Ghioca M, Grasu M, Herlea V, Hrehoret D, Iacob R, Lupescu I, Matei E, Popescu I, Gheorghe L.   +16 more
europepmc   +1 more source

A Randomized, Double-Blind, Placebo-Controlled Study of the PD-1 Inhibitor Cetrelimab in Chronic Hepatitis B. [PDF]

J Viral Hepat
Asselah T, Kakuda TN, Kulke S, Walenta E, Halter RJ, Ariyawansa J, Verheijden S, Lenz O, Aguilar Z, Lonjon-Domanec I, Biermer M.   +10 more
europepmc   +1 more source